US FDA commissioner nominee clears procedural hurdle as agency's opioid policy remains a charged political issue.
FDA Commissioner nominee Scott Gottlieb has overcome opioids policy, conflict of interest and other concerns to reach the final confirmation stage.
The Senate invoked cloture on the Gottlieb nomination May 8 with a 57-41 vote, which sets an end to debate...
Recent studies show that spaceflight can significantly weaken astronauts’ immune systems, making them more susceptible to infections and health complications during and after missions. Understanding these changes is crucial for ensuring the safety of future long-duration space travelers.
Recent ODAC meetings suggest the FDA will expand focus beyond applications with pending approval decisions to refining trial designs and drug labels for competitors.
The US FDA Commissioner pushed for a rebalancing of the US’s pharmaceutical supply chains while also stressing that there is a role for US-China commerce that would be risky to compromise.
Recent ODAC meetings suggest the FDA will expand focus beyond applications with pending approval decisions to refining trial designs and drug labels for competitors.
The US FDA Commissioner pushed for a rebalancing of the US’s pharmaceutical supply chains while also stressing that there is a role for US-China commerce that would be risky to compromise.
